BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 8616059)

  • 1. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K; Löwenberg B
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
    Heal JM; Blumberg N; Masel D
    Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
    Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
    Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-matching procedure for the selection of platelet donors for alloimmunized patients.
    Waters AH; Minchinton RM; Bell R; Ford JM; Lister TA
    Br J Haematol; 1981 May; 48(1):59-68. PubMed ID: 7018556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microplate ELISA for the detection of platelet alloantibodies: comparison with the platelet immunofluorescence test.
    Sintnicolaas K; van der Steuijt KJ; van Putten WL; Bolhuis RL
    Br J Haematol; 1987 Jul; 66(3):363-7. PubMed ID: 3304393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective platelet crossmatching for selection of compatible random donors.
    Freedman J; Hooi C; Garvey MB
    Br J Haematol; 1984 Jan; 56(1):9-18. PubMed ID: 6367808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
    Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of HLA antibodies by platelet crossmatching techniques.
    McGrath K; Holdsworth R; Veale M; Bishop J; Wolf M
    Transfusion; 1988; 28(3):214-6. PubMed ID: 3285524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
    Kickler TS; Ness PM; Braine HG
    Am J Clin Pathol; 1988 Jul; 90(1):69-72. PubMed ID: 3389345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Can thrombocyte crossmatching improve the efficiency of platelet transfusion?].
    Weisbach V; Zeiler T; Zingsem J; Musch R; Heuft HG; Eckstein R
    Beitr Infusionsther; 1990; 26():160-2. PubMed ID: 1703820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of flow cytometry as a platelet crossmatching procedure.
    Gates K; MacPherson BR
    Cytometry; 1994 Sep; 18(3):123-8. PubMed ID: 7813332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transnational validation of the Australian algorithm for virtual crossmatch allocation in kidney paired donation.
    Böhmig GA; Fidler S; Christiansen FT; Fischer G; Ferrari P
    Hum Immunol; 2013 May; 74(5):500-5. PubMed ID: 23380140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ABO Matching of Platelet Transfusions in Critically Ill Children.
    Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC; ;
    Pediatr Crit Care Med; 2019 Feb; 20(2):e61-e69. PubMed ID: 30422914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
    Menitove JE; Duquesnoy RJ
    Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of platelet crossmatch results by Solid Phase Red Cell Adherence Assay (SPRCA) with post-transfusion platelet count increment in adult hemato-oncology patients of a tertiary care oncology centre in India.
    Desai P; Sontakke P; Rajadhyaksha S; Navkudkar A
    Transfus Apher Sci; 2020 Oct; 59(5):102842. PubMed ID: 32586771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti-peroxidase in alloimmunized patients.
    Yam P; Petz LD; Scott EP; Santos S
    Br J Haematol; 1984 Jun; 57(2):337-47. PubMed ID: 6375714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO incompatible platelets: risks versus benefit.
    Dunbar NM; Ornstein DL; Dumont LJ
    Curr Opin Hematol; 2012 Nov; 19(6):475-9. PubMed ID: 22914587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
    Fagundes IS; Franz JM; Jobim MS; Arend A; Merzoni J; Cardone JM; Gil B; Sekine L; Jobim LF
    Hum Immunol; 2020 May; 81(5):197-201. PubMed ID: 32067841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet transfusion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantation.
    Marktel S; Napolitano S; Zino E; Cappelli B; Chiesa R; Poli F; Crocchiolo R; Ronchi P; Rossini S; Ciceri F; Roncarolo MG; Fleischhauer K
    Pediatr Transplant; 2010 May; 14(3):393-401. PubMed ID: 20070557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.